The mechanism of a high-affinity allosteric inhibitor of the serotonin transporter
The serotonin transporter (SERT) terminates serotonin signaling and its activity is modulated by antidepressants. Here authors reveal the mechanistic details underlying the coupling between the two binding sites in SERT and a high-affinity ligand for the allosteric site.
Main Authors: | Per Plenge, Ara M. Abramyan, Gunnar Sørensen, Arne Mørk, Pia Weikop, Ulrik Gether, Benny Bang-Andersen, Lei Shi, Claus J. Loland |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2020-03-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-020-15292-y |
Similar Items
-
The antidepressant drug vilazodone is an allosteric inhibitor of the serotonin transporter
by: Per Plenge, et al.
Published: (2021-08-01) -
Genetically encoded photocrosslinkers locate the high-affinity binding site of antidepressant drugs in the human serotonin transporter
by: Hafsteinn Rannversson, et al.
Published: (2016-04-01) -
Conformational dynamics of the human serotonin transporter during substrate and drug binding
by: Ingvar R. Möller, et al.
Published: (2019-04-01) -
Discovery of High-Affinity Noncovalent Allosteric KRAS Inhibitors That Disrupt Effector Binding
by: Michael J. McCarthy, et al.
Published: (2019-02-01) -
Characterization of the Allosteric Properties of Thermus thermophilus Phosphofructokinase and the Sources of Strong Inhibitor Binding Affinity and Weak Inhibitory Response
by: Shubina-McGresham, Maria
Published: (2012)